MIDAS PHARMA GMBH
Germany
Warfarin Sodium, amorphous
Warfarin Sodium, amorphous; API; EP, USP, JP, ANVISA; [129-06-6]
Description
Warfarin Sodium, amorphous is a synthetically synthesized Active Pharmaceutical Ingredient, produced under cGMP, compliant with EP monograph. Its CAS-N° reads [129-06-6]. It is used to treat or prevent blood clots in veins or arteries, which can reduce the risk of stroke, heart attack, or other serious conditions. Detailed specification, Certificate of Analysis and samples are available on request. Warfarin sodium is a 4-hydroxycumarin, these are known as vitamin K antagonists. Vitamin K antagonists are anticoagulants that encroach on the blood clotting cascade. Since the substance can have significant fluctuations in its effectiveness, depending on the genotype, the blood clotting levels for dose tuning should be tested regularly.
Pharmaceutical products
- warfarin
- anticoagulant
- heart attack
Product features
CAS | 129-06-6 |
Product Information | API |
Route of Synthesis | Synthetic |
Patent Expiry | EU, US - expired |
Indication | Anticoagulant, Tromboembosism |
Dosage | Oral and iv formulation |
View this product on the company site
Warfarin Sodium, amorphous
Other products from this business
More information on the company's website
http://ky.to/www.midas-pharma....